UBR5 and cancer: The aim of the current study was therefore to determine any associations between EDD overexpression and patient outcome, in particular disease recurrence in patients with serous ovarian cancer, by correlating protein expression as measured by IHC to clinicopathological parameters in a retrospective cohort of 151 primary cancers.